Amedeo Smart

Free Medical Literature Service


 

Amedeo

Lung Cancer

  Free Subscription

Articles published in
Mol Carcinog
    February 2024
  1. FURUSAWA T, Cavero R, Liu Y, Li H, et al
    Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer.
    Mol Carcinog. 2024 Feb 27. doi: 10.1002/mc.23705.
    >> Share

  2. LI Q, Li J, Wang J, Wang J, et al
    PLEK2 mediates metastasis and invasion via alpha5-nAChR activation in nicotine-induced lung adenocarcinoma.
    Mol Carcinog. 2024;63:253-265.
    >> Share

  3. HU M, Cheng H, Yang Y, Xu L, et al
    Valproic acid increased the efficacy of EGFR TKIs on EGFR/TP53 co-mutated lung cancers and downregulated mutant-p53 levels.
    Mol Carcinog. 2024;63:275-285.
    >> Share

    January 2024
  4. LI J, Li Y, Sun X, Wei L, et al
    Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.
    Mol Carcinog. 2024 Jan 30. doi: 10.1002/mc.23686.
    >> Share

  5. ZHANG X, Zhao Y, Yiminniyaze R, Zhu N, et al
    CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.
    Mol Carcinog. 2024;63:61-74.
    >> Share

    December 2023
  6. HUA T, Zhang C, Fu Y, Qin N, et al
    Integrative analyses of N6-methyladenosine-associated single-nucleotide polymorphisms (m6A-SNPs) identify tumor suppressor gene AK9 in lung cancer.
    Mol Carcinog. 2023 Dec 5. doi: 10.1002/mc.23669.
    >> Share

  7. JIANG T, Li N, Xu H, Sun L, et al
    Identification of ATAD3A as a key regulator in non-small cell lung cancer by promoting STAT3-induced cell proliferation and tumor angiogenesis.
    Mol Carcinog. 2023 Dec 5. doi: 10.1002/mc.23667.
    >> Share

  8. ZHANG C, Sun Q, Zhao J, Jiang N, et al
    JSI-124 inhibits cell proliferation and tumor growth by inducing autophagy and apoptosis in murine malignant mesothelioma.
    Mol Carcinog. 2023;62:1888-1901.
    >> Share

    November 2023
  9. CHEN J, Kang G, Lei W, Li J, et al
    DUSP22 suppresses tumor progression by directly dephosphorylating AKT in non-small cell lung cancer.
    Mol Carcinog. 2023 Nov 8. doi: 10.1002/mc.23654.
    >> Share

    October 2023
  10. LONG T, Li J, Yin T, Liu K, et al
    A genetic variant in gene NDUFAF4 confers the risk of non-small cell lung cancer by perturbing hsa-miR-215 binding.
    Mol Carcinog. 2023 Oct 3. doi: 10.1002/mc.23642.
    >> Share

    August 2023
  11. QIAO R, Zhu Q, Di F, Liu C, et al
    Hypomethylation of DYRK4 in peripheral blood is associated with increased lung cancer risk.
    Mol Carcinog. 2023 Aug 2. doi: 10.1002/mc.23612.
    >> Share

    July 2023
  12. ZHANG B, Zhao B, Han S, Chen S, et al
    CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF1.
    Mol Carcinog. 2023 Jul 26. doi: 10.1002/mc.23599.
    >> Share

  13. WANG B, Shen XY, Pan LY, Li Z, et al
    The HDAC2-MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c-Myc and cyclin D1.
    Mol Carcinog. 2023 Jul 4. doi: 10.1002/mc.23604.
    >> Share

  14. SHAMEEM M, Bagherpoor AJ, Nakhi A, Dosa P, et al
    Mitochondria-targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen species.
    Mol Carcinog. 2023 Jul 4. doi: 10.1002/mc.23603.
    >> Share

    June 2023
  15. CHEN C, Xue N, Liu K, He Q, et al
    USP12 promotes nonsmall cell lung cancer progression through deubiquitinating and stabilizing RRM2.
    Mol Carcinog. 2023 Jun 21. doi: 10.1002/mc.23593.
    >> Share

  16. GE W, Gong Y, Li Y, Wu N, et al
    IL-17 induces non-small cell lung cancer metastasis via GCN5-dependent SOX4 acetylation enhancing MMP9 gene transcription and expression.
    Mol Carcinog. 2023 Jun 9. doi: 10.1002/mc.23585.
    >> Share

    May 2023
  17. FAN J, Hong T, Zhao X, Liang S, et al
    A two-stage genome-wide association study identified four potential early-onset nonsmall cell lung cancer risk loci based on 26,652 participants in Chinese population.
    Mol Carcinog. 2023 May 26. doi: 10.1002/mc.23561.
    >> Share

  18. PETER RM, Sarwar MS, Mostafa SZ, Wang Y, et al
    Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS-mutant human lung cancer cells.
    Mol Carcinog. 2023 May 5. doi: 10.1002/mc.23551.
    >> Share

  19. GE P, Chen X, Liu J, Jing R, et al
    Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFbeta/Smad3/EMT signaling.
    Mol Carcinog. 2023 May 3. doi: 10.1002/mc.23547.
    >> Share

    April 2023
  20. YANG XR, Pi C, Zhang YC, Chen ZH, et al
    Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer.
    Mol Carcinog. 2023 Apr 17. doi: 10.1002/mc.23541.
    >> Share

  21. ADHIKARY G, Shrestha S, Naselsky W, Newland JJ, et al
    Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation.
    Mol Carcinog. 2023;62:438-449.
    >> Share

    March 2023
  22. CHEN KJ, Huang JH, Shih JH, Gu DL, et al
    Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma.
    Mol Carcinog. 2023;62:348-359.
    >> Share

    January 2023
  23. CHEN D, Fan S, Wang J, Liang Y, et al
    Cip2a induces arginine biosynthesis and promotes tumor progression in non-small cell lung cancer.
    Mol Carcinog. 2023 Jan 27. doi: 10.1002/mc.23507.
    >> Share

    December 2022
  24. HOU J, Li W, Zhang S, Tan D, et al
    UHRF1 plays an oncogenic role in small cell lung cancer.
    Mol Carcinog. 2022 Dec 20. doi: 10.1002/mc.23493.
    >> Share

  25. ZHU Y, Chen B, Pan H, Sun L, et al
    PLIC11 drives lung cancer progression through regulating the YY1/PIWIL4 axis.
    Mol Carcinog. 2022 Dec 20. doi: 10.1002/mc.23496.
    >> Share

  26. ZHANG Z, Chen Q, Huang C, Rao D, et al
    Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression.
    Mol Carcinog. 2022;61:1161-1176.
    >> Share

    October 2022
  27. OHTAKI Y, Kawabata-Iwakawa R, Nobusawa S, Goto Y, et al
    Molecular and expressional characterization of tumor heterogeneity in pulmonary carcinosarcoma.
    Mol Carcinog. 2022;61:924-932.
    >> Share

  28. XIE J, Liao G, Feng Z, Liu B, et al
    ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2/beta-catenin signaling pathway.
    Mol Carcinog. 2022;61:897-909.
    >> Share

    September 2022
  29. QIAO Z, Kong Y, Zhang Y, Qian L, et al
    Phosphoproteomics of extracellular vesicles integrated with multiomics analysis reveals novel kinase networks for lung cancer.
    Mol Carcinog. 2022 Sep 23. doi: 10.1002/mc.23462.
    >> Share

  30. QIAN L, Vallega KA, Yao W, Wang D, et al
    Therapeutic potential of the novel Bcl-2/Bcl-XL dual inhibitor, APG1252, alone or in combination against non-small cell lung cancer.
    Mol Carcinog. 2022 Sep 6. doi: 10.1002/mc.23458.
    >> Share

    August 2022
  31. GU J, Zhang X, Jiang G, Li Q, et al
    ARHGEF40 promotes non-small cell lung cancer proliferation and invasion via the AKT-Wnt axis by binding to RhoA.
    Mol Carcinog. 2022 Aug 24. doi: 10.1002/mc.23457.
    >> Share

  32. JIANG X, Qin N, Hua T, Wei X, et al
    Functional characterization and clinical significance of super-enhancers in lung adenocarcinoma.
    Mol Carcinog. 2022;61:776-786.
    >> Share

    June 2022
  33. NASELSKY W, Adhikary G, Shrestha S, Chen X, et al
    Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype.
    Mol Carcinog. 2022;61:537-548.
    >> Share

    May 2022
  34. CHEN AS, Liu H, Wu Y, Luo S, et al
    Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival.
    Mol Carcinog. 2022 May 3. doi: 10.1002/mc.23400.
    >> Share

    April 2022
  35. YANG P, Li X, Wen Q, Zhao X, et al
    Quercetin attenuates the proliferation of arsenic-related lung cancer cells via a caspase-dependent DNA damage signaling.
    Mol Carcinog. 2022 Apr 18. doi: 10.1002/mc.23408.
    >> Share

  36. KANG N, Qiu WJ, Wang B, Tang DF, et al
    Role of hemoglobin alpha and hemoglobin beta in non-small-cell lung cancer based on bioinformatics analysis.
    Mol Carcinog. 2022 Apr 8. doi: 10.1002/mc.23404.
    >> Share

    December 2021
  37. RIZWAN MN, Ma Y, Nenkov M, Jin L, et al
    Tumor-derived exosomes: Key players in non-small cell lung cancer metastasis and their implication for targeted therapy.
    Mol Carcinog. 2021 Dec 12. doi: 10.1002/mc.23378.
    >> Share

    October 2021
  38. XIAO M, Cui S, Zhang L, Yu T, et al
    Benzo[a]pyrene diol epoxide-induced transformed cells identify the significance of hsa_circ_0051488, a ERCC1-derived circular RNA in pulmonary squamous cell carcinoma.
    Mol Carcinog. 2021;60:684-701.
    >> Share

    August 2021
  39. HU W, Ma Y, Zhao C, Yin S, et al
    Methylseleninic acid overcomes programmed death-ligand 1-mediated resistance of prostate cancer and lung cancer.
    Mol Carcinog. 2021 Aug 19. doi: 10.1002/mc.23340.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016